1 |
Acth (acthar) gel |
Corticotropin |
[1] D00146 D00146 💬 |
MC2R [1] MC2R 💬 |
Aldosterone synthesis and secretion [5] Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
066 [1] 66 💬 |
2 |
Acthar |
- |
- |
- |
- |
002 [9] 2 , 13, 14, 46, 49, 50, 66, 84, 222 💬 |
3 |
Acthar 80 unit injection |
- |
- |
- |
- |
066 [1] 66 💬 |
4 |
Acthar gel |
- |
- |
- |
- |
013 [6] 13, 46, 49, 50, 84, 222 💬 |
5 |
Acthar gel (acth) |
Corticotropin |
[1] D00146 D00146 💬 |
MC2R [1] MC2R 💬 |
Aldosterone synthesis and secretion [5] Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
013 [1] 13 💬 |
6 |
Acthar gel (adrenocorticotropic hormone) |
Corticotropin |
[1] D00146 D00146 💬 |
MC2R [1] MC2R 💬 |
Aldosterone synthesis and secretion [5] Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
084 [1] 84 💬 |
7 |
Acthar gel 40 units twice weekly |
- |
- |
- |
- |
084 [1] 84 💬 |
8 |
Acthar gel 80 units twice weekly. |
- |
- |
- |
- |
084 [1] 84 💬 |
9 |
Acthar high dose (80 u) |
- |
- |
- |
- |
049 [1] 49 💬 |
10 |
Acthar injectable product |
- |
- |
- |
- |
046 [1] 46 💬 |
11 |
Acthar low dose (40 u) |
- |
- |
- |
- |
049 [1] 49 💬 |
12 |
Adrenocorticotropic hormone (acth) gel (h.p. acthar®) |
Corticotropin |
[1] D00146 D00146 💬 |
MC2R [1] MC2R 💬 |
Aldosterone synthesis and secretion [5] Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
013 [1] 13 💬 |
13 |
Corticotropin |
Corticotropin |
[1] D00146 D00146 💬 |
MC2R [1] MC2R 💬 |
Aldosterone synthesis and secretion [5] Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
002 [7] 2 , 13, 46, 75, 78, 84, 222 💬 |
14 |
Corticotropin-releasing hormone |
Corticorelin |
[2] D00146 D00146, D03905 D03905 💬 |
CRHR1 [3] CRHR1, CRHR2, MC2R 💬 |
Aldosterone synthesis and secretion [6] Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Long-term depression, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
075 [1] 75 💬 |
15 |
H.p. acthar gel |
- |
- |
- |
- |
046 [5] 46, 49, 50, 84, 222 💬 |
16 |
H.p. acthar gel (repository corticotropin injection) |
Corticotropin |
[1] D00146 D00146 💬 |
MC2R [1] MC2R 💬 |
Aldosterone synthesis and secretion [5] Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
013 [1] 13 💬 |
17 |
H.p. acthar® gel |
- |
- |
- |
- |
014 [1] 14 💬 |
18 |
Other: corticotropin releasing hormone (crh) |
Corticotropin |
[1] D00146 D00146 💬 |
MC2R [1] MC2R 💬 |
Aldosterone synthesis and secretion [5] Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
078 [1] 78 💬 |
19 |
Ovine corticotropin-releasing hormone (ocrh) |
Corticorelin |
[2] D00146 D00146, D03905 D03905 💬 |
CRHR1 [3] CRHR1, CRHR2, MC2R 💬 |
Aldosterone synthesis and secretion [6] Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Long-term depression, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
075 [1] 75 💬 |
20 |
Repository corticotropin injection |
Corticotropin |
[1] D00146 D00146 💬 |
MC2R [1] MC2R 💬 |
Aldosterone synthesis and secretion [5] Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
002 [5] 2 , 13, 46, 84, 222 💬 |
21 |
Repository corticotropin injection -treatment extension |
Corticotropin |
[1] D00146 D00146 💬 |
MC2R [1] MC2R 💬 |
Aldosterone synthesis and secretion [5] Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway |
084 [1] 84 💬 |